pentobarbital will minimize the extent or impact of cinacalcet by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

Reserve concomitant prescribing of those drugs in patients for whom other procedure solutions are inadequate. Limit dosages and durations into the bare minimum essential. Keep track of intently for signs of respiratory despair and sedation.

pentobarbital will minimize the level or outcome of duvelisib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration with a powerful CYP3A inducer decreases duvelisib area beneath the curve (AUC), which may lessen duvelisib efficacy.

pentobarbital will minimize the extent or influence of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Stay clear of coadministration of bedaquiline with powerful CYP3A4 inducers as a result of prospective for reduced therapeutic effect

Minor (one)pentobarbital will decrease the extent or effect of paclitaxel protein bound by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.

pentobarbital will minimize the level or effect of atazanavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.

pentobarbital will reduce the level or impact of tofacitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Loss of, or reduced reaction to tofacitinib may perhaps manifest when coadministered with powerful CYP3A4 inducers

pentobarbital will reduce the extent or impact of voriconazole by influencing hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Not known.

pentobarbital will lower the level or influence of nelfinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

If this drug is employed for the duration of pregnancy, or read more Should the patient results in being pregnant while using this drug, the patient needs to be apprised of the likely hazard to the fetus

pentobarbital will lessen the extent or outcome of piroxicam by influencing hepatic enzyme CYP2C9/10 metabolism. Slight/Importance Unidentified.

pentobarbital will decrease the extent or impact of rabeprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.

pentobarbital will minimize the extent or outcome of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Monitor patients previously on buprenorphine subdermal implant who demand freshly-initiated cure with CYP3A4 inducer for signals and signs or symptoms of withdrawal.

pentobarbital will lower the level or influence of nicardipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.